Published in Immunotherapy Weekly, December 5th, 2007
"The pathogenesis of pain in MS is diverse as are the possible effects of CB at different sites of CB receptors in the peripheral and central nervous system, this may explain the variable impact on individual patients. The aim of this review is to summarize pre-clinical and clinical studies to explain this variability from a neuropharmacological point of view," wrote F.S. Lienau and colleagues, University of Lubeck.
The researchers concluded: "Future studies are needed to examine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly